162 related articles for article (PubMed ID: 2724303)
1. Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indan derivatives.
Kanao M; Watanabe Y; Kimura Y; Saegusa J; Yamamoto K; Kanno H; Kanaya N; Kubo H; Ashida S; Ishikawa F
J Med Chem; 1989 Jun; 32(6):1326-34. PubMed ID: 2724303
[TBL] [Abstract][Full Text] [Related]
2. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T
J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529
[TBL] [Abstract][Full Text] [Related]
3. Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of thromboxane synthetase.
Takami M; Tsukada W
Pharmacol Res; 1998 Aug; 38(2):133-9. PubMed ID: 9721601
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
Martinez GR; Walker KA; Hirschfeld DR; Bruno JJ; Yang DS; Maloney PJ
J Med Chem; 1992 Feb; 35(4):620-8. PubMed ID: 1311763
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities.
Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H
Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1510-20. PubMed ID: 8795270
[TBL] [Abstract][Full Text] [Related]
6. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.
Takami M; Takata Y; Matsumoto K; Ono S; Tsukada W
Ann N Y Acad Sci; 1991; 629():407-9. PubMed ID: 1952565
[No Abstract] [Full Text] [Related]
7. [(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
Martinez GR; Walker KA; Hirschfeld DR; Maloney PJ; Yang DS; Rosenkranz RP
J Med Chem; 1989 Apr; 32(4):890-7. PubMed ID: 2704033
[TBL] [Abstract][Full Text] [Related]
8. New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors.
Cimetière B; Dubuffet T; Landras C; Descombes JJ; Simonet S; Verbeuren TJ; Lavielle G
Bioorg Med Chem Lett; 1998 Jun; 8(11):1381-6. PubMed ID: 9871770
[TBL] [Abstract][Full Text] [Related]
9. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
[TBL] [Abstract][Full Text] [Related]
10. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
Nagao T; Nagamatsu T; Suzuki Y
Eur J Pharmacol; 1996 Nov; 316(1):73-80. PubMed ID: 8982653
[TBL] [Abstract][Full Text] [Related]
11. N-aminoalkylsuccinimides as local anaesthetics. III. 1,2,3,4-Tetrahydronaphthalene-2-, indane-1-, and indane-2-spiro-3'-pyrrolidine-2'-5'-diones.
Sandberg R; Domeij KE; Stening G; Willman N; Akerman B
Acta Pharm Suec; 1980; 17(4):177-82. PubMed ID: 7468237
[No Abstract] [Full Text] [Related]
12. Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
Nagao T; Ito M; Nagamatsu T; Suzuki Y
Eur J Pharmacol; 1994 Jul; 259(3):233-42. PubMed ID: 7982449
[TBL] [Abstract][Full Text] [Related]
13. [Effects of thromboxane A2 synthetase inhibitor, DP-1904 on the action of vasoactive substances in rabbit blood vessel smooth muscle preparations].
Shimizu K; Kobayashi J; Iwanaga T; Kuratomi Y; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):591-6. PubMed ID: 2615099
[TBL] [Abstract][Full Text] [Related]
14. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
[No Abstract] [Full Text] [Related]
15. Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitors.
Manley PW; Allanson NM; Booth RF; Buckle PE; Kuzniar EJ; Lad N; Lai SM; Lunt DO; Tuffin DP
J Med Chem; 1987 Sep; 30(9):1588-95. PubMed ID: 3305945
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and thromboxane synthetase inhibitory activity of di- or tetrahydrobenzo[b]thiophenecarboxylic acid derivatives.
Amemiya Y; Terada A; Wachi K; Miyazawa H; Hatakeyama N; Matsuda K; Oshima T
J Med Chem; 1989 Jun; 32(6):1265-72. PubMed ID: 2724299
[TBL] [Abstract][Full Text] [Related]
17. Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridines.
Archibald JL; Bradley G; Opalko A; Ward TJ; White JC; Ennis C; Shepperson NB
J Med Chem; 1990 Feb; 33(2):646-52. PubMed ID: 2299629
[TBL] [Abstract][Full Text] [Related]
18. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
19. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Hardee MM; Moore JN; Hardee GE
Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
[TBL] [Abstract][Full Text] [Related]
20. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]